THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
MEDICINE MONOGRAPH CODE: [12.25] ID: TIP-MED-000257

Clotrimazole (1% Topical Antifungal & 100/500 mg Vaginal Pessary)

Active Ingredient / Scientific Identity: Clotrimazole • Class: Topical Imidazole Broad-Spectrum Antifungal (Ergosterol Synthesis Inhibitor)

⚖️ Compare Profile
Generic / Entity NameClotrimazole (1% Topical Antifungal & 100/500 mg Vaginal Pessary) ([12.25])
Verified Indian Brands / RefGeneric Compendial Entry (No Commercial Brand Claimed)
Pharmacological ClassTopical Imidazole Broad-Spectrum Antifungal (Ergosterol Synthesis Inhibitor)
Available Dosage FormsCream / Lotion / Dusting Powder: 1% w/w; Vaginal Pessary/Tablet: 100 mg, 200 mg, 500 mg; Vaginal Gel: 2%; Mout
Regulatory ClassificationNon-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommend
Key Warning & Review DateRenal: Not applicable (minimal systemic absorption). • Hepatic: Not applicable.
Reviewed: 2026-11-10
Safety Matrix:⚖️ Legal Status: Non-Schedule / OTC or Schedule K Permitted Preparati✔️ Standard Clinical Dispensing Precautions

1. Clinical & Scientific Overview

Clotrimazole (1% Topical Antifungal & 100/500 mg Vaginal Pessary) (TIP-MED-000257, Reference Code [12.25]) is classified under Dermatological & Topical Antiseptic Preparations (Ch 12) as a Topical Imidazole Broad-Spectrum Antifungal (Ergosterol Synthesis Inhibitor). Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).

Verified Indian Market Examples / Compendial Status:
Representative Indian Market Examples (Edition 2.7 Ch 12 [12.25], p. 167): Candid, Canesten, Clocip, Surfaz — Strengths & Dosage Forms: Cream / Lotion / Dusting Powder: 1% w/w; Vaginal Pessary/Tablet: 100 mg, 200 mg, 500 mg; Vaginal Gel: 2%; Mouth Paint: 1% w/v; Ear Drops: 1% w/v.
Representative Indian Market Examples (Edition 2.7 Ch 12 [12.25], p. 167): Candid, Canesten, Clocip, Surfaz — Strengths & Dosage Forms: Cream / Lotion / Dusting Powder: 1% w/w; Vaginal Pessary/Tablet: 100 mg, 200 mg, 500 mg; Vaginal Gel: 2%; Mouth Paint: 1% w/v; Ear Drops: 1% w/v.
Dosage Forms & Available Strengths:
Cream / Lotion / Dusting Powder: 1% w/w; Vaginal Pessary/Tablet: 100 mg, 200 mg, 500 mg; Vaginal Gel: 2%; Mouth Paint: 1% w/v; Ear Drops: 1% w/v.
Routes: Oral / Parenteral / Topical as specified by formulation

3. Mechanism of Action & Pharmacodynamics

Inhibits fungal cytochrome P450 14-alpha-lanosterol demethylase -> depletes fungal cell-membrane ergosterol and causes toxic intracellular peroxide accumulation.

4. Therapeutic Indications & Evidence-Supported Uses

  • Dermatophytosis (tinea corporis, tinea cruris, tinea pedis), cutaneous candidiasis, pityriasis versicolor, vulvovaginal candidiasis, fungal otomycosis, and oropharyngeal thrush

🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.

5. Educational Dosage Context, Formulations & Administration

Educational Dosing & Regimen Summary: Adult: Cutaneous Tinea/Candidiasis: Apply 1% cream thinly BD-TDS for 2-4 weeks (continue for 1-2 weeks AFTER rash clears). Vulvovaginal Candidiasis: 500 mg pessary single night dose OR 200 mg pessary nightly for 3 nights OR 100 mg nightly for 6 nights. Oral Thrush: Apply 1% mouth paint 3-4 times daily. • Paediatric: Cutaneous Candidiasis / Napkin Dermatitis: Apply 1% cream BD for 7-14 days.

Administration & Meal Timing: See Administration & Counselling below. | Standard clinical schedule per indication.

6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment

Absorption & Disposition:
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Metabolism & Biotransformation:
Renal: Not applicable (minimal systemic absorption). • Hepatic: Not applicable.
Elimination & Renal Adjustment:
Renal: Not applicable (minimal systemic absorption). • Hepatic: Not applicable.
Hepatic Impairment Considerations:
Renal: Not applicable (minimal systemic absorption). • Hepatic: Not applicable.

7. Contraindications, Precautions & High-Risk Warnings

Contraindications & Red-Flag Precautions:
  • Contraindications: Hypersensitivity to imidazole antifungals. • Precautions: CRITICAL INDIAN ANTIFUNGAL STEWARDSHIP WARNING: Strongly discourage patients from buying irrational OTC fixed-dose combinations containing Clotrimazole + Clobetasol/Betamethasone + Neomycin (e.g., Fourderm/Quadriderm/Panderm) for fungal ringworm ('daad')—topical potent steroids suppress local skin immunity and cause recalcitrant steroid-modified tinea ('tinea incognito') and striae!

Key Clinical Precautions: Renal: Not applicable (minimal systemic absorption). • Hepatic: Not applicable.

8. Adverse Effects Profile

Common & Mechanism-Related Adverse Effects:
  • Mild local erythema, stinging, pruritus, or vaginal burning.
  • Allergic contact dermatitis.
Serious / Dose-Limiting Adverse Effects:
  • Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.

9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions

  • Vaginal clotrimazole pessaries/creams contain mineral oil excipients that weaken latex condoms and diaphragms for up to 72 hours after use

10. Clinical Monitoring, Patient Counselling & Storage

Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.

Pharmacist Patient Counselling Points:

  • Patient Counselling Checklist: Apply cream 2 cm beyond the visible edge of the ringworm patch and continue applying for 2 full weeks AFTER the skin looks completely normal to kill dormant spores; keep groin/skin folds dry; never use steroid-mixed creams on fungal infections.
  • Meal & Clock Timing Instruction: See Administration & Counselling below. (Standard clinical schedule per indication.)
  • Missed Dose Protocol: Take as soon as remembered unless close to next scheduled dose; never double the dose.
  • Geriatric Dispensing Pearl: Schedule: OTC / Schedule H | NLEM 2022: Yes | Compendia: IP 2026 / NFI 7th Ed 2026 / NLEM 2022 / BNF 90th Ed

Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Cream / Lotion / Dusting Powder: 1% w/w; Vaginal Pessary/Tablet: 100 mg, 200 mg, 500 mg; Vaginal Gel: 2%; Mouth Paint: 1% w/v; Ear Drops: 1% w/v.

11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)

THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
svg-v339-01-adme-12-step-journey — 8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

12. Authoritative References, Regulatory Sources & Editorial Disclaimer

Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 12 [12.25] (p. 167)

Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)

Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT

Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.